Subscribe to Newsletter
Discovery & Development Drug Discovery, Standards & Regulation

Exploring the Bounties of the Brain

Brain disorders are the cause of a worsening healthcare crisis. Neurodevelopmental, neurodegenerative and neuropsychiatric diseases are all intrinsically linked to high societal and economic costs. The WHO claims that these conditions are a “major cause of lost years of healthy life (1)”  and, in 2014 alone, the US dished out roughly US$800 billion to cover the cost of patient care and the loss of productivity caused by these diseases (2). As our societies age, these challenges are expected to worsen. United Nations statistics suggest that 16 percent of the world’s population will be over the age of 65  by 2050 (3). And with a lack of treatments to halt – or even slow – these broad and varied conditions, there are significant hurdles to overcome. 

Fortunately, an increasing number of companies appear interested in tackling the issue. Reports estimate that the market has a compound annual growth rate of 6.4 percent, with the sector expected to generate US$520.8 million per year by 2025 (4). But, questions arise as to whether the renewed interest in the field will mark the start of long lasting change both for neuroscience programs and the patients waiting for treatment options. 

But many are proving that they are invested in seeing a change for patients. We’ve selected a handful of articles highlighting the work that is helping to improve outcomes for patients living with neurological disorders.

On the Cusp of Change

R&D Without Borders

Bridging the Barrier

It’s All Connected

Beyond the Barrier


Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. WHO, “Global burden of neurological disorders estimates and projections” Neurological disorders: Public health challenges, WHO, 2006.
  2. CL Gooch et al, “The burden of neurological disease in the United States: A summary report and call to action,” Ann Neurol, 81,479 (2017).
  3. United Nations, “Ageing” (2021). Available at
  4. Persistence Market Research, “Neuroscience Market” (2021). Available at
About the Author
Maryam Mahdi

Deputy Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine